Managing the Side Effects of Psychotropic Medications, Second Edition


Book Description

"This book has been divided into three main sections. Part I deals with global issues that bear on the assessment and formulation of possible adverse effects and with pertinent concepts related to basic pharmacology, physiology, and medical monitoring. The chapters in Part II present information organized by individual organ systems or specific medical circumstances rather than by drugs or drug classes. This approach seems to provide a logical and comprehensible format that allow readers to search out information as referenced by a particular side effect (and its varied potential causes) and to locate a discussion of practical management strategies. Part III focuses on summary recommendations covering all the material presented in the book and is followed by helpful appendixes on self-assessment questions and resources for practitioners. The book is meant to serve as a ready reference that simultaneously provides scientific and scholarly discussion of available treatment options and presents their scientific rationales."--page xx.




Medical Management of Psychotropic Side Effects


Book Description

This book is a practical guide for psychiatrists to use when treating patients for medical issues. Over the past 10-20 years, the number of medications prescribed for psychiatric illnesses has steadily increased, and psychiatric practitioners are frequently called upon to manage medical issues and side effects that result from psychotropic treatment. Covering a wide range of conditions from thyroid disorders to cardiac disease, this book is a helpful resource for understanding common adverse medical effects that occur when psychotropic drugs are administered. Presented in a practical format, each chapter discusses management of a particular medical problem or side effect and then provides a summary and flowchart of the major points highlighted in that chapter. Each chapter contains an overview of key medications causing a particular side effect. The book also includes special topics such as psychotropic prescribing in medical illness and tips on electrocardiographic interpretation. This easy-to-reference book aims to bridge the gap between medicine and psychiatry by elaborating on medical conditions seen in routine outpatient psychiatric practice. It serves as an invaluable tool for mental health providers, nurses, health educators, and pharmacologists alike. ​ ​​




Managing the Side Effects of Psychotropic Medications


Book Description

Information about new psychotropic drugs, a summary of advances in knowledge about identifiable risk factors for adverse effects, and updated recommendations on viable "antidote" management strategies -- including novel pharmacotherapies for tardive dyskinesia and newer agents for weight loss -- are among the features of this new, second edition of Managing the Side Effects of Psychotropic Medications. Where other psychopharmacology textbooks -- and, indeed, most internships and residencies in psychiatry -- lack a solid basis in primary care medicine, this guide bridges that educational gap, offering a thorough examination of all the effects of taking a psychotropic drug as well practical clinical advice on how to manage complications that arise. The book is divided into three parts: The first deals with global issues that affect the assessment and formulation of possible adverse effects, as well as with pertinent concepts related to basic pharmacology, physiology, and medical monitoring. The second part presents information organized by individual organ systems or specific medical circumstances. The final part focuses on summary recommendations covering all the material presented in the book and is followed by helpful appendixes and self-assessment questions and resources for practitioners. This new edition includes: Updated summaries about what psychiatrists should know regarding drug-drug interactions, iatrogenic cardiac arrhythmias, drug pressor effects and orthostatic hypotension, and drug rashes; as well as updated discussions on avoiding lithium nephrotoxicity, handling adverse effect emergencies, and understanding new FDA classifications about drug safety during pregnancy An expanded discussion on the strengths and limitations of pharmacogenetic testing to predict adverse drug effects, as well as information about new treatments for sexual dysfunction, sleep disturbances, cognitive complaints, and other maladies Revised summary tables to aid rapid assessment and management An expanded section on supplemental resources An updated and expanded self-assessment section with more key questions Busy clinicians will find in Managing the Side Effects of Psychotropic Medications an accessible reference that provides both scientific and scholarly discussion of the consequences of drug therapies they may prescribe (or avoid), the range of available strategies to effectively manage adverse effects, and the scientific and practical implications of their treatment decisions.




Practical Management of the Side Effects of Psychotropic Drugs


Book Description

This practical reference provides a clinically oriented management guide to the secondary results of all major classes of psychotropic medications used in North America. Practical Management of the Side Effects of Psychotropic Drugs describes the symptoms, frequency, and treatment options to certain drug reactions addresses general issues of side effect management, such as mechanisms of action, differential diagnosis, patient education, quality of life, and potential legal ramifications explores which compounds are tolerated best in patients with dysthymia, post-traumatic stress disorder, and certain personality disorders covers agents applied in the control of alcoholism and drug abuse discusses dealing with special populations, including the elderly, minorities, and medically ill patients and more! With over 900 references and tables, Practical Management of the Side Effects of Psychotropic Drugs is ideally suited for clinical psychiatrists, primary care physicians, internists, neurologists, psychotherapists, pharmacologists, clinical psychopharmacologists, neuropsychopharmacologists, pharmaceutical and behavioral scientists, and graduate and medical school students in these disciplines.




Mental Disorders in Primary Care


Book Description

An invaluable guide to psychiatric presentation, diagnosis and treatment in a primary care setting.




Pharmacological Treatment of Mental Disorders in Primary Health Care


Book Description

This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.




Reactions to Psychotropic Medication


Book Description

After thousands of clinical trials, the efficacy of psychotropic drugs in the treatment of psychiatric disorders has become well established. However, the very success of these drugs has meant that many patients with chronic illnesses will receive them for a significant part of their lifetime. Side effects and other adverse reactions are an unfortunate but unavoidable component of successful pharmacotherapy. In deed, the main emphasis in new drug development is often on the search for compounds that have fewer side effects, although no one has as yet found an effective drug without them. Therefore, it is important for clinicians to be aware of side effect reaction profiles, because they are often a major determining factor in the choice of therapy. After more than three decades of major breakthroughs in the development of psychotropic drugs, reactions to these medications are still frequently reported in the current liter ature, and information about well-known reactions is con stantly refined. This book is an attempt to systematically collect and organize this large body of data and present it in an easy-to-use form. All chapters follow the same reaction oriented logic, and each important reaction is discussed using the same consistent subdivisions. The more clinically impor tant reactions appear in the body of each chapter; the more unusual or rarely reported reactions are briefly characterized in the miscellaneous section at the end of each chapter.




Psychotropic Drug Handbook


Book Description

This succinct handbook provides students and practitioners with clinically relevant psychotropic drug information. The Eighth Edition is designed as a reference text that also teaches by delivering informative narrative text under standard headlines with references. Its focus goes beyond drug information to cover pharmacotherapy applications. The book provides detailed, well-referenced, evidence-based information on a wide range of psychotropic drugs, including mood stabilizers, antidepressants, and antianxiety agents. This edition has new chapters on pediatric and geriatric psychopharmacotherapy; new content on antipsychotics, hypnotics, medications used in treating alcoholism and substance dependence, and electroconvulsive therapy; and new algorithms, appendices, and tables.




Clinical Handbook of Psychotropic Drugs


Book Description

Includes bibliography, glossary, and an extensive index which cross-references generic and trade names. New editions are available on a subscription basis.




The Social Worker and Psychotropic Medication


Book Description

A generation of social work students has benefited from Kia Bentley and Joseph Walsh’s practical approach to the social worker’s role in psychopharmacology. New coauthor Shannon Hughes brings even more fresh ideas to the updated Fifth Edition. Important updates include: • updated and expanded drug information and tables including names, typical dosages, potential adverse effects, as well as never-before-included FDA approval information • updated content on psychogenomics as well as added new content on medication use with sexual minorities and gender diverse people • more explicit criticisms of the chemical imbalance theory and the use of the term “anosognosia” • more comprehensive guidelines for talking to children, parents, and teachers about psychiatric medication • expanded content on shared decision-making, including a presentation on what we think “truth-telling” about medication looks like in the 21st century • explicit content on the centrality of avoiding both subtle and overt coercion • new section on medication discontinuation and “deprescribing” and the role of social work in supporting these trends • expanded section on prescription-writing privileges to account for the recognition of physician assistants, nurse practitioners, and pharmacists in those roles • new section on the use of psychedelics in psychiatry • acknowledgement of the potential impact of the COVID-19 pandemic and telemedicine on the future of both social work and psychopharmacological practice • significantly increased attention to the human rights/social justice interface of social work and psychopharmacology